SK283636B6 - Deriváty dekahydroizochinolínkarboxamidu, farmaceutické prípravky, ktoré ich obsahujú a ich použitie - Google Patents

Deriváty dekahydroizochinolínkarboxamidu, farmaceutické prípravky, ktoré ich obsahujú a ich použitie Download PDF

Info

Publication number
SK283636B6
SK283636B6 SK1222-99A SK122299A SK283636B6 SK 283636 B6 SK283636 B6 SK 283636B6 SK 122299 A SK122299 A SK 122299A SK 283636 B6 SK283636 B6 SK 283636B6
Authority
SK
Slovakia
Prior art keywords
derivative according
alkyl
compound
pharmaceutical composition
group
Prior art date
Application number
SK1222-99A
Other languages
English (en)
Slovak (sk)
Other versions
SK122299A3 (en
Inventor
Kim F. Albizati
Siegfried Reich
Michael D. Varney
Kanyin E. Zhang
Takuo Kobayashi
Original Assignee
Agouron Pharmaceuticals, Inc.
Japan Tobacco, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharmaceuticals, Inc., Japan Tobacco, Inc. filed Critical Agouron Pharmaceuticals, Inc.
Publication of SK122299A3 publication Critical patent/SK122299A3/sk
Publication of SK283636B6 publication Critical patent/SK283636B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/22Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SK1222-99A 1997-03-13 1998-03-12 Deriváty dekahydroizochinolínkarboxamidu, farmaceutické prípravky, ktoré ich obsahujú a ich použitie SK283636B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81595197A 1997-03-13 1997-03-13
PCT/US1998/004735 WO1998040357A2 (en) 1997-03-13 1998-03-12 Hiv protease inhibitors

Publications (2)

Publication Number Publication Date
SK122299A3 SK122299A3 (en) 2000-05-16
SK283636B6 true SK283636B6 (sk) 2003-11-04

Family

ID=25219265

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1222-99A SK283636B6 (sk) 1997-03-13 1998-03-12 Deriváty dekahydroizochinolínkarboxamidu, farmaceutické prípravky, ktoré ich obsahujú a ich použitie

Country Status (35)

Country Link
EP (1) EP0970055A2 (xx)
JP (1) JP2001516350A (xx)
KR (1) KR100511089B1 (xx)
CN (1) CN1179948C (xx)
AP (1) AP1358A (xx)
AR (1) AR012556A1 (xx)
AU (1) AU743078B2 (xx)
BG (1) BG63540B1 (xx)
BR (1) BR9808867A (xx)
CA (1) CA2284163A1 (xx)
CO (1) CO4940496A1 (xx)
CZ (1) CZ296647B6 (xx)
EA (1) EA002378B1 (xx)
EE (1) EE04114B1 (xx)
GE (1) GEP20022764B (xx)
HR (1) HRP980112A2 (xx)
HU (1) HUP0001380A3 (xx)
IL (2) IL131870A0 (xx)
IS (1) IS5176A (xx)
MX (1) MXPA99008395A (xx)
MY (1) MY117535A (xx)
NO (1) NO315555B1 (xx)
NZ (1) NZ337706A (xx)
OA (1) OA11196A (xx)
PA (1) PA8448801A1 (xx)
PE (1) PE58799A1 (xx)
PL (1) PL192786B1 (xx)
SA (1) SA98181116B1 (xx)
SK (1) SK283636B6 (xx)
SV (1) SV1998000038A (xx)
TR (1) TR199902508T2 (xx)
TW (1) TW200517112A (xx)
UA (1) UA57772C2 (xx)
WO (1) WO1998040357A2 (xx)
ZA (1) ZA982047B (xx)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors

Also Published As

Publication number Publication date
PL335672A1 (en) 2000-05-08
CZ319199A3 (cs) 2000-06-14
EA002378B1 (ru) 2002-04-25
ZA982047B (en) 1998-09-28
CO4940496A1 (es) 2000-07-24
PL192786B1 (pl) 2006-12-29
EE04114B1 (et) 2003-08-15
NO994415D0 (no) 1999-09-10
JP2001516350A (ja) 2001-09-25
WO1998040357A2 (en) 1998-09-17
TR199902508T2 (xx) 2000-02-21
GEP20022764B (en) 2002-08-26
CZ296647B6 (cs) 2006-05-17
IS5176A (is) 1999-09-10
BG103727A (en) 2000-04-28
HUP0001380A3 (en) 2001-12-28
NO315555B1 (no) 2003-09-22
AU6457598A (en) 1998-09-29
AP9901648A0 (en) 1999-09-30
OA11196A (en) 2003-05-21
AP1358A (en) 2004-12-03
EA199900823A1 (ru) 2000-04-24
KR20000076236A (ko) 2000-12-26
CN1179948C (zh) 2004-12-15
NZ337706A (en) 2001-04-27
EE9900416A (et) 2000-04-17
AU743078B2 (en) 2002-01-17
UA57772C2 (uk) 2003-07-15
BR9808867A (pt) 2000-07-11
EP0970055A2 (en) 2000-01-12
IL131870A0 (en) 2001-03-19
SA98181116B1 (ar) 2006-10-04
WO1998040357A3 (en) 1998-11-26
TW200517112A (en) 2005-06-01
BG63540B1 (bg) 2002-04-30
PA8448801A1 (es) 2000-05-24
IL131870A (en) 2006-04-10
HUP0001380A2 (hu) 2000-09-28
AR012556A1 (es) 2000-11-08
CA2284163A1 (en) 1998-09-17
MY117535A (en) 2004-07-31
SV1998000038A (es) 1999-02-15
NO994415L (no) 1999-11-10
HRP980112A2 (en) 1998-12-31
MXPA99008395A (es) 2003-08-12
CN1253548A (zh) 2000-05-17
SK122299A3 (en) 2000-05-16
PE58799A1 (es) 1999-07-12
KR100511089B1 (ko) 2005-08-31

Similar Documents

Publication Publication Date Title
AU700417B2 (en) Protease inhibitors
BG62567B1 (bg) Инхибитори на hiv-протеазата
JPH06271534A (ja) Aidsの処置のために有用なhiv−プロテアーゼ阻害剤
JP2006022106A (ja) Hivプロテアーゼ阻害剤としてのn−(3−アミノ−2−ヒドロキシブチル)スルホンアミド誘導体
JPH06234789A (ja) Aidsの処置のために有用なhiv−プロテアーゼ阻害剤
NZ243452A (en) Inhibitors of hv protease and pharmaceutical compositions thereof
JPH07179417A (ja) Aidsの処置のために有用なhiv−プロテアーゼ阻害剤
JP3195462B2 (ja) エイズ治療用hivプロテアーゼ阻害剤
JPH06234728A (ja) Aidsの処置のために有用なhiv−プロテアーゼ阻害剤
JPH09509657A (ja) 中間体および製造のための方法
US6001851A (en) HIV protease inhibitors
SK283636B6 (sk) Deriváty dekahydroizochinolínkarboxamidu, farmaceutické prípravky, ktoré ich obsahujú a ich použitie

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20100312